About Mag Venture
Mag Venture is a company based in Farum (Denmark) founded in 2007 by Stig Wanding Andersen. It operates as a B2B. Mag Venture offers products and services including R20 Therapy Package, R30 Standard Level Therapy Package, R30 with Flow Arm Package, and R30 Package with Localite-Value Navigation. Mag Venture operates in a competitive market with competitors including Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others.
- Headquarter Farum, Denmark
- Founders Stig Wanding Andersen
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website magventure.com
- Social LinkedIn Instagram YouTube
- Legal Name Magventure A/S
Products & Services of Mag Venture
Mag Venture offers a comprehensive portfolio of products and services, including R20 Therapy Package, R30 Standard Level Therapy Package, R30 with Flow Arm Package, and R30 Package with Localite-Value Navigation.
Compact system for standard rTMS protocols in therapy
High-performance system for various rTMS protocols
Therapy system with liquid cooling for extended use
Neuronavigated system for refined rTMS protocols
Apps and channels of Mag Venture
its YouTube channel MagVenture has 1.98K subscribers and 30 videos.
Videos from Mag Venture
The most watched videos on Mag Venture's YouTube channel, MagVenture (1.98K subscribers). Click a video to play it here.
More on MagVenture.
People of Mag Venture
27 people are tracked at Mag Venture (8 in leadership, 19 in team).
| Name | Role | Group |
|---|---|---|
Stig Wanding Andersen | Founder, CEO | Leadership |
Lucas Godoy | Head Of Marketing, Commercial Excellence, And Product Management | Leadership |
Patrick Donahue | Vice President Of Service & Support | Leadership |
Tomas Dønnergaard Larsen | Head Of Partner Sales | Leadership |
Christian Wanding | Chief Commercial Officer (cco) | Leadership |
Lauren Schultheiss | Director Strategic Marketing | Leadership |
Lars Elmo Stuhr | Head Of Global Technical Support | Leadership |
Yordan Todorov | Senior Vp, Operations & Technical Sales | Leadership |
Vibeke Emborg | Customer Service / Shipping Assistant | Team |
Mateus Ferreira | Quality And Technical Support Manager | Team |
Marianne J. Winther | IFU & User Communications Manager | Team |
Austin J. Sharp | Regional Sales Manager | Team |
Sejla Tabakovic | Global Marketing Manager | Team |
Eddie Orzechowski | Technical Sales Engineer | Team |
Samuel Jacobs | National Sales Manager (uk) | Team |
Bernd Fötsch | National Sales Manager Deutschland Österreich | Team |
Stacey K. | Installation And Training Manager | Team |
Itbs Hospital Hispania Neurociencias Rtms Tdcs, Tec | Empresa Electromedicina | Team |
Esben Rosenberg Sørensen | Global Marketing Manager | Team |
Nicoline Möglich | Sales Marketing Support Manager | Team |
7 more people are available in the full profile.
Complete people profiles for Mag Venture
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Mag Venture
Mag Venture operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Flow Neuroscience, NeuroStar, Magstim, Soterix Medical and Neuroprex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| flowneuroscience.com | 2016 | Malmo, Sweden | $11.9M | – | Provider of a wearable device for stress and anxiety management | |
| neurostar.com | 2003 | Malvern, United States | $118.69M | 151 | Non-invasive TMS therapy is provided for major depressive disorder treatment. | |
| magstim.com | 1990 | Whitland, United Kingdom | $32.05M | 87 | Neurotechnology solutions for EEG, TMS, and tDCS are developed. | |
| soterixmedical.com | 2008 | New York, United States | – | – | Non-invasive neuromodulation devices for mood disorders are manufactured. | |
| neuroprexinc.com | 2012 | Santa Clara, United States | $50,000 | – | Wearable devices are developed to modulate tissues for neurological diseases. | |
| neuroqore.com | 2012 | Ottawa, Canada | $1.76M | – | Monophasic rTMS systems for depression treatment are developed by NeuroQore. | |
| axilumrobotics.com | 2011 | Strasbourg, France | – | – | Developer of robot for assisting healthcare professionals | |
| amperemedical.com.hk | 2018 | Kowloon, China | – | – | Develops innovative medical devices for brain treatment. | |
| tmsworkbook.com | 2018 | Nashville, United States | – | – | Digital platform for TMS therapy modules and patient assessments. |
Detailed competitors of Mag Venture
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Mag Venture
The website of Mag Venture (magventure.com) receives about 10.9K visits a month.
- Monthly visits10.9K
▼ 4% vs previous month
Websites whose visitors overlap most with Mag Venture. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| magstim.com | 100% | 10.8K | #2,045,419 | View details |
Latest news on Mag Venture
Complete news archive for Mag Venture
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Mag Venture
10 companies that operate in the same segment as Mag Venture (Neurology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | – | |
AI-driven drug discovery platform for neurological diseases based on patients biomarkers | 2019 | San Francisco, California, United States | USD 144.72 M | – | 76 | |
Small molecule drugs for rare diseases are developed. | 1998 | South Plainfield, New Jersey, United States | USD 248.1 M | USD 1.73 B | 939 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | – | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mag Venture
Mag Venture was founded in 2007.
Mag Venture is headquartered in Farum, Denmark.
Stig Wanding Andersen is the current CEO of Mag Venture. They have also founded this company.
MagVenture is a Danish company focused on non-invasive Transcranial Magnetic Stimulation (TMS) technology for mental health treatments like depression and OCD. They design, produce, and sell TMS systems to professionals such as psychiatrists and researchers worldwide. Based in Farum, Denmark, they collaborate with global partners to advance neurostimulation applications, ensuring high-quality devices for clinical and diagnostic use.
Mag Venture's top competitors include NeuroStar, Flow Neuroscience and Magstim.
Mag Venture offers R20 Therapy Package, R30 Standard Level Therapy Package, R30 with Flow Arm Package, and R30 Package with Localite-Value Navigation.
Mag Venture operates through Magventure A/S.